Optiver Holding
LXRX icon

Optiver Holding’s Lexicon Pharmaceuticals LXRX Stock Holding History

Optiver Holding’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-52,595
Closed -$60.5K – 2565
2025
Q4 		$60.5K Sell
52,595
-23,298
-31% -$32K ﹤0.01% 877
2025
Q3 		$102K Buy
75,893
+72,858
+2,401% +$82.7K ﹤0.01% 689
2025
Q2 		$2.87K Buy
3,035
+1,192
+65% +$772 ﹤0.01% 1308
2025
Q1 		$849 Buy
1,843
+643
+54% +$406 ﹤0.01% 1289
2024
Q4 		$886 Buy
+1,200
New +$1.45K ﹤0.01% 991
2024
Q3 		– Sell
-155
Closed -$260 – 1037
2024
Q2 		$260 Buy
+155
New +$278 ﹤0.01% 880

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Optiver Holding's LXRX Position: Q1 2026 in Review

Optiver Holding sold out of Lexicon Pharmaceuticals (LXRX) in Q1 2026, closing a stake of 52,595 shares — an estimated $60.5K sold.

Optiver Holding first reported a position in LXRX in Q2 2024 and held it in 6 quarters. The position peaked at $102K in Q3 2025. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

  • Optiver Holding reported no remaining Lexicon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Optiver Holding sold 52,595 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $60.5K.
  • Optiver Holding first reported a position in Lexicon Pharmaceuticals in Q2 2024 and held it in 6 quarters.
  • Optiver Holding's Lexicon Pharmaceuticals position peaked at $102K in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.